Blog
RSS FeedPosted by Michael Wonder on 13 Jan 2025
Peter’s prostate cancer diagnosis came as a shock. Now, he wants to protect his kids.
14 January 2025 - Peter had no symptoms when he was diagnosed with prostate cancer. Now, he’d like to see an ...
Posted by Michael Wonder on 12 Jan 2025
2,000 people to benefit from medicine for osteoporosis and people with high blood calcium and cancer
10 January 2025 - PHARMAC is widening access to a medicine called denosumab for people with osteoporosis. ...
Posted by Michael Wonder on 08 Jan 2025
Korea's only RET inhibitor, Retevmo, seeks insurance coverage again
6 January 2025 - Lilly Korea is again pursuing reimbursement for Retevmo (selpercatinib), the only RET inhibitor in Korea. ...
Posted by Michael Wonder on 06 Jan 2025
Price must be right to put obesity pill on the PBS
6 January 2025 - Whether to fully subsidise the new generation weight loss drugs such as Mounjaro and Ozempic for ...
Posted by Michael Wonder on 06 Jan 2025
Global pharma giants push for weight loss drugs to be added to PBS
6 January 2025 - Taxpayers would fund popular weight loss drugs for people with severe obesity under a proposal from ...
Posted by Michael Wonder on 03 Jan 2025
New Zealand Pharmaceutical Schedule - 1 January 2025
1 January 2025 - The January 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 02 Jan 2025
New and expanded PBS listings for breast and prostate cancer
2 January 2025 - Australians with prostate and breast cancer now have affordable access to affordable new and expanded medicines ...
Posted by Michael Wonder on 01 Jan 2025
Schedule of Pharmaceutical Benefits - 1 January 2025
1 January 2025 - The January 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 27 Dec 2024
Labor leaves genetics loophole for life insurers
21 December 2024 - One of the last barriers to widespread genetic testing — discrimination against obtaining life insurance — ...
Posted by Michael Wonder on 22 Dec 2024
PHARMAC consulting on six medicines for New Zealanders
19 December 2024 - PHARMAC is asking for feedback on proposals to fund six medicines for cancer and antibiotic resistant ...
Posted by Michael Wonder on 15 Dec 2024
Securing cheaper medicines for people with severe eczema
14 December 2024 - The Australian Government has ensured thousands of Australians living with severe eczema will continue to have ...
Posted by Michael Wonder on 14 Dec 2024
Novartis and the pan-Canadian Pharmaceutical Alliance achieve milestone agreement for Pluvicto
13 December 2024 - Targeted radioligand therapy closer to public reimbursement for eligible Canadian patients with PSMA positive metastatic castration ...
Posted by Michael Wonder on 14 Dec 2024
Roche Canada and the pan-Canadian Pharmaceutical Alliance successfully complete negotiations for Tecentriq SC (atezolizumab solution for subcutaneous injection)
13 December 2024 - Roche Canada today announced that it successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance for Tecentriq ...
Posted by Michael Wonder on 14 Dec 2024
Deal struck to secure place of eczema drug on PBS
13 December 2024 - Health Minister Mark Butler has struck a deal to secure the place of a “life-changing” eczema ...
Posted by Michael Wonder on 10 Dec 2024
PHARMAC seeks feedback to fund medicines for liver and ovarian cancer
9 December 2024 - PHARMAC is consulting on a proposal to fund bevacizumab (branded as Vegzelma) as a cancer medicine ...